A detailed history of Mackenzie Financial Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 478,744 shares of TMDX stock, worth $30 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
478,744
Previous 606,750 21.1%
Holding current value
$30 Million
Previous $91.4 Million 17.76%
% of portfolio
0.11%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$135.68 - $176.11 $17.4 Million - $22.5 Million
-128,006 Reduced 21.1%
478,744 $75.2 Million
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $4.32 Million - $8.97 Million
-59,536 Reduced 8.94%
606,750 $91.4 Million
Q1 2024

May 10, 2024

BUY
$70.86 - $89.93 $15.1 Million - $19.1 Million
212,671 Added 46.88%
666,286 $49.3 Million
Q4 2023

Jan 30, 2024

BUY
$36.74 - $81.08 $16.7 Million - $36.8 Million
453,615 New
453,615 $35.8 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.99B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.